The largest database of trusted experimental protocols

Nanoject 2 injector

Manufactured by Drummond
Sourced in United States

The Nanoject II injector is a laboratory equipment designed for the precise injection of small volumes of liquids. It features an automated injection system capable of delivering nanoliter-scale volumes with high accuracy and repeatability. The core function of the Nanoject II is to provide a reliable and precise method for the controlled delivery of samples, reagents, or other liquids in various laboratory applications.

Automatically generated - may contain errors

55 protocols using nanoject 2 injector

1

Mosquito Ookinete Injection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
After ookinete purification from in vitro culture described above, each of 40 mosquitoes (4 to 5 days old) was injected intrathoracically with 138 nl of PBS containing 690 ookinetes using a Nanoject II injector (Drummond Scientific, USA). The hemocoel oocysts within the mosquitoes were observed under the stereoscopic fluorescence microscope (M165FC, Leica) at indicated times after injection.
+ Open protocol
+ Expand
2

Dengue Virus Infection in Mosquitoes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female mosquitoes at 3–5 days post-emergence were anesthetized by CO2. Each mosquito was intrathoracically inoculated with 69 nl of DENV-2 16681 (6.9 × 102 PFU in 69 nl) grown in C6/36 cell culture using a Nanoject II injector (Drummond, Broomall, Pennsylvania, USA) as described previously [19 (link)]. Mosquitoes were then transferred into cylindrical containers fitted with nylon mesh on the top. Saliva was collected from infected mosquitoes on day 7 after infection. Viral titer was determined by plaque assay [19 (link)].
+ Open protocol
+ Expand
3

Fly-based IIV-6 Infection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fly stocks were grown on standard cornmeal-agar molasses at 25°C. w[1118] strain was used as wildtype flies. Loquacious transgenic flies were introduced elsewhere (Fukunaga et al., 2012 (link)). Two transgenic lines expressing loqs specific isoforms were used here: Loqs-PD deficient (w[1118];loqs[KO]/CyO;P{w+,FLAG-Loqs-PB}/TM3,Sb[1]) and the Control (w[1118];loqs[KO]/CyO;P{w+,FLAG-Loqs-PB-PD}/TM3,Sb[1]) (Fukunaga et al., 2012 (link)). For IIV-6 infections, 4 to 6-day-old female flies were intrathoracic injected (Nanoject II injector; Drummond Scientific) with 5 X 105 TCID50 (w[1118] flies for SOLiD platform sequencing) or 5,000 TCID50 (Control and Loqs-PD deficient flies for Illumina platform sequencing) diluted in 69 nL of non-supplemented Schneider’s medium. The flies were incubated at 25°C and harvested in TRIzol reagent (Invitrogen). Samples were homogenized in the Mini-Beadbeater homogenizer (BioSpec). RNA and DNA were extracted according to TRIzol’s protocol.
+ Open protocol
+ Expand
4

Stereotaxic AAV-mediated transgene delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adeno-associated virus (AAV) (~5×1012 gc/ml) encoding murine preproSST transgene fused with GFP via T2A self-cleavage spacer sequence was prepared by AAVpro purification kit (TaKaRa Bio, Japan) and bilaterally injected into PFC (AP +1.9 mm; ML ±0.15 mm; DV −0.8 mm), using a stereotaxic apparatus (RWD Life Science, USA). A total of 0.5 µl of purified virus was delivered on each hemisphere over a 5-min period using glass microcapillary pipettes (1.14 mm O.D. x 3.5” length x 0.53mm I.D.) and the Nanoject II injector (Drummond, PA, USA). Mice (8 to 10 weeks of age) were anesthetized by isoflurane inhalation during the stereotaxic injection, and used for downstream assays 3 weeks post-injection.
+ Open protocol
+ Expand
5

Gene Silencing in Anopheles stephensi

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the dsRNA products for silencing genes such as TEP1, Rel1, GNBP-B1, and NOX5 were generated using a cDNA template from A. stephensi, and the MEGAscriptTM RNAi Kit (Thermo Fisher Scientific) as previously described3 (link),7 (link). In brief, 3-day-old female A. stephensi were cold-anesthetized and injected with 3 mg/mL of dsRNA using a Nanoject II injector (Drummond Scientific Co., Broomall, PA, USA), 2 days prior to infection. Silencing efficiency was examined at day 2 post-knockdown by qPCR, as described above. Primers designed for specific transcript targets are listed in Supplementary Table 3.
+ Open protocol
+ Expand
6

Clodronate Liposomes Depletion of Mosquito Hemocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The day prior to CSPmut infection, naïve female mosquitoes (3–5 days old) were injected intrathoracically with either 69 nL of control liposomes or CLDs (Standard Macrophage Depletion Kit; Clodrosome® + Encapsome®; Encapsula Nano Sciences, Brentwood, TN, USA) using a Nanoject II injector (Drummond Scientific Co.). As previously described22 (link), 1:5 dilutions of liposomes and CLDs in 1 × PBS were used for the experiments. Following liposome injection, mosquitoes were infected with CSPmut parasites. The effect of clodronate liposomes on the depletion of mosquito hemocytes was determined by the expression of cell markers NimB2 (hemocytes), LRIM15 (granulocytes), and SCRB9 (oenocytoids) with real-time PCR as previously reported26 (link). The change in oocyst melanization, the number of sporozoites, and relative expression of TEP1 were determined as described above.
+ Open protocol
+ Expand
7

Microinjection of Plasmid DNA into Xenopus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Glass capillaries (3.5-inch length, 0.02-inch width: Drummond Scientific) were pulled (Sutter Instrument Co P-97) and the tip was broken under a dissecting scope using forceps. We injected a solution of 0.25–0.27 μg/μl of purified plasmid DNA (pCMV-GFP, Addgene #11153) mixed with 0.01% Fast Green using a Nanoject II injector (Drummond Scientific). Injection volumes are listed below with the corresponding protocol. We used plasmid concentrations based on that reported for X. laevis [3 (link), 16 , 46 ].
+ Open protocol
+ Expand
8

Targeted dsRNA Depletion of Mosquito Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
To deplete TEP1, LRIM1, TEP1*S, or TEP1*R, dsRNAs for TEP1, LRIM1, LacZ, TEP1*S (dsS), and TEP1*R (dsR) were produced from plasmids containing the dsRNA-target sequence flanked by two T7 promoters [5 (link),21 (link),44 ]. To deplete HPX2, dsRNA for HPX2 was produced from PCR-amplified fragments flanked with two T7 promoters as described [7 (link)]. RNA synthesis and purification were performed using MegaScript and MegaClear kits (Ambion). RNA concentrations were measured by Nanodrop (Thermo Scientific) before annealing 3 μg/μl of sense and anti-sense RNAs by boiling. DsRNAs were injected (69 nl) into the thorax of CO2-immobilized 1-d-old mosquitoes using a glass capillary mounted onto a Nanoject II injector (Drummond).
+ Open protocol
+ Expand
9

Injection of Flies with ThT and PGN

Check if the same lab product or an alternative is used in the 5 most similar protocols
In Figure 5C, and in related Figure S2, male and female flies were injected with 64 nL of the following solutions using Nanoject II injector (Drummond Scientific): untreated: no injection; DMSO: 5% DMSO in sterile Dulbecco’s modified PBS (Corning); ThT: 1 mM ThT, 5% DMSO in PBS; DMSO+PGN: 5% DMSO, 0.5 mg/ml E. coli strain 1106 PGN in PBS; ThT+PGN: 1 mM ThT, 0.5 mg/ml PGN in PBS. In Figure 5D, male flies were injected with 64 nL of indicated concentrations of ThT diluted in 5% DMSO in PBS, +/− 0.5 mg/ml PGN. Flies were harvested 1 h post-injection, snap-frozen on dry-ice, homogenized in TRIzol® reagent (Invitrogen), and total RNAs were extracted according to the manufacturer’s protocol. In Figure 5E, and in related Figure S3, flies were injected and harvested as described above, but 40 μM TCT or 400 μM TCT was used instead of PGN.
+ Open protocol
+ Expand
10

AAV-Mediated Somatostatin Overexpression in PFC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adeno-associated virus (AAV) (~5x10 12 gc/ml) encoding murine preproSST transgene fused with GFP via T2A self-cleavage spacer sequence was prepared by AAVpro purification kit (TaKaRa Bio, Japan) and bilaterally injected into PFC (AP +1.9 mm; ML ±0.15 mm; DV -0.8 mm), using a stereotaxic apparatus (RWD Life Science, USA). A total of 0.5 µl of purified virus was delivered on each hemisphere over a 5-min period using glass microcapillary pipettes (1.14 mm O.D. x 3.5" length x 0.53mm I.D.) and the Nanoject II injector (Drummond, PA, USA). Mice (8 to 10 weeks of age) were anesthetized by isoflurane inhalation during the stereotaxic injection, and used for downstream assays 3 weeks post-injection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!